<DOC>
	<DOCNO>NCT00527150</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability pharmacokinetics escalate multiple oral dos varenicline AMT 8 control release formulation 14 day adult smoker .</brief_summary>
	<brief_title>Multiple Dose , Dose Escalation Study Varenicline Controlled Release Formulation Adult Smokers</brief_title>
	<detailed_description />
	<mesh_term>Varenicline</mesh_term>
	<criteria>Healthy male and/or female subject age 18 55 year , inclusive . Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test . Currently smoke smoke average least 10 cigarette per day past year , period abstinence great 3 continuous month past year . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Pregnant nursing woman exclude ; woman childbearing potential ( WOCBP ) unwilling unable use acceptable method contraception outline protocol least 14 day prior study medication administration completion protocolrequired procedure exclude . Subjects estimate creatinine clearance ( CLcr ) &lt; 80 mL/min derive use method Cockcroft Gault .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>